Literature DB >> 12921252

Assessment of factors influencing blood pressure control in a managed care population.

Tanya M Romain1, Rosalie P Patel, Andrea M Heaberlin, Barbara J Zarowitz.   

Abstract

We attempted to determine the percentage of patients meeting Health Plan Employer Data Information Set (HEDIS) criteria for blood pressure control (< or = 140/90 mm Hg), to identify factors contributing to differences in blood pressure control among those who met HEDIS criteria and those who did not, and to assess compliance with blood pressure management recommendations established by the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC-VI) for diabetes mellitus and myocardial infarction. In this retrospective analysis, we randomly selected 502 patient records from three primary care clinics in southeast Michigan. All patients were commercial members of one health maintenance organization, 74% of whom met HEDIS criteria for blood pressure control. These patients took fewer blood pressure drugs throughout the year (p=0.023) and had lower antihypertensive drug costs than those who did not achieve HEDIS blood pressure goals (p=0.016). According to JNC-VI criteria, 46% of diabetic patients were at their blood pressure goal of below 130/85 mm Hg and 71.6% were managed with angiotensin-converting enzyme inhibitors or angiotensin receptor blockers. Eighty-five percent of patients were taking beta-blockers after myocardial infarction. The percentage of patients achieving target blood pressure exceeded the national average and was associated with few antihypertensive drugs and low drug cost. Effective and appropriate management of blood pressure in people with diabetes remains a challenge.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12921252     DOI: 10.1592/phco.23.8.1060.32879

Source DB:  PubMed          Journal:  Pharmacotherapy        ISSN: 0277-0008            Impact factor:   4.705


  5 in total

Review 1.  Desirable therapeutic characteristics of an optimal antihypertensive agent.

Authors:  Lisa Mustone Alexander
Journal:  Drugs       Date:  2006       Impact factor: 9.546

Review 2.  Systems for care of hypertension in the United States.

Authors:  Lawrence R Krakoff
Journal:  J Clin Hypertens (Greenwich)       Date:  2006-06       Impact factor: 3.738

3.  Patient, clinician and logistic barriers to blood pressure control among adult hypertensives in rural district hospitals in Rwanda: a cross-sectional study.

Authors:  J P Sibomana; R L McNamara; T D Walker
Journal:  BMC Cardiovasc Disord       Date:  2019-10-21       Impact factor: 2.298

4.  Blood pressure control by drug group in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

Authors:  William C Cushman; Charles E Ford; Paula T Einhorn; Jackson T Wright; Richard A Preston; Barry R Davis; Jan N Basile; Paul K Whelton; Robert J Weiss; Arnaud Bastien; Donald L Courtney; Bruce P Hamilton; Kent Kirchner; Gail T Louis; Tamrat M Retta; Donald G Vidt
Journal:  J Clin Hypertens (Greenwich)       Date:  2008-10       Impact factor: 3.738

5.  Clinical and pathological analysis of the kidney in patients with hypertensive nephropathy.

Authors:  Xiang-Chuan Wang; Chun-Hui Liu; Yun-Jing Chen; Yang Wu; Lei-Shan Yang; Hong-Min Liu; Hai-Li Liao
Journal:  Exp Ther Med       Date:  2013-09-18       Impact factor: 2.447

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.